Cresset Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$433K	Buy	15,040 +142	+1%	+$4.08K	﹤0.01%	1126
2025 Q1	$500K	Buy	14,898 +7,674	+106%	+$257K	﹤0.01%	1057
2024 Q4	$369K	Sell	7,224 -1,849	-20%	-$94.5K	﹤0.01%	1215
2024 Q3	$464K	Buy	9,073 +11	+0.1%	+$562	﹤0.01%	1532
2024 Q2	$406K	Buy	+9,062	New	+$406K	﹤0.01%	1514